TOP STORIES
respiratory
Asthma

Biomarker response to asthma treatment shouldn’t be neglected

Biomarkers can guide treatment choice in severe asthma but may also provide clinically useful information from the subsequent effects of treatment on biomarkers, Australian researchers say. A review of the evidence, led by Professor John Upham from the University of...

Biomarkers can guide treatment choice in severe asthma but may also provide clinically useful information from the subsequent effects of...

Read more
Lung cancer

Lung cancer outcomes gap still wide for Indigenous Australians

Indigenous people with lung cancer are much more likely to die than non-Indigenous people, despite having similar stage at diagnosis and receiving similar treatments, a new study from the NT has found. A review of outcomes for 91 Indigenous and...

Indigenous people with lung cancer are much more likely to die than non-Indigenous people, despite having similar stage at diagnosis...
Allergy

Some wheezy infants have lower risk of asthma in adulthood: Melbourne Atopy Cohort

Infants who have early transient wheeze in the first two years of life have a reduced risk of atopic disease and asthma in later childhood and adolescence, a Victorian study has found The findings that early transient wheeze is a benign...

Infants who have early transient wheeze in the first two years of life have a reduced risk of atopic disease...

Antiretroviral combination has no effect on COVID-19 outcomes

The antiretroviral combination of lopinavir/ritonavir has no significant mortality benefit in hospitalised COVID-19 patients, preliminary results from the RECOVERY trial show. The findings come after a routine review of emerging data by the independent Data Monitoring Committee led them...

The antiretroviral combination of lopinavir/ritonavir has no significant mortality benefit in hospitalised COVID-19 patients, preliminary results from the RECOVERY...